Tertiary lymphoid structures: new immunotherapy biomarker

被引：6

作者：

Yang, Fangyuan ^{[1
]}

Yang, Jiahe ^{[2
]}

Wu, Meijuan ^{[2
]}

Chen, Cheng ^{[2
]}

Chu, Xiaoyuan ^{[1
,2
]}

机构：

[1] Nanjing Med Univ, Jinling Hosp, Dept Med Oncol, Nanjing, Peoples R China

[2] Nanjing Univ, Jinling Hosp, Affiliated Hosp, Dept Med Oncol,Med Sch, Nanjing, Peoples R China

来源：

FRONTIERS IN IMMUNOLOGY | 2024年 / 15卷

基金：

中国国家自然科学基金;

关键词：

tertiary lymphoid structures; cancer; immunotherapy; biomarker; cancer prognosis; HIGH ENDOTHELIAL VENULES; PLASMA-CELLS; CANCER; RESPONSES; SURVIVAL; METASTASES; MARKER; ORGAN;

D O I：

10.3389/fimmu.2024.1394505

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Immunotherapy shows substantial advancement in cancer and is becoming widely used in clinical practice. A variety of biomarkers have been proposed to predict the efficacy of immunotherapy, but most of them have low predictive ability. Tertiary lymphoid structures (TLSs), the aggregation of multiple lymphocytes, have been found to exist in various tumor tissues. TLSs have been shown to correlate with patient prognosis and immunotherapy response. This review summarizes the characteristics of TLSs and the inducing factors of TLS formation, presents available evidence on the role of TLSs in predicting immunotherapy response in different cancers, and lastly emphasizes their predictive potential for neoadjuvant immunotherapy efficacy.

引用

页数：11

共 112 条

[1] STING Agonists as Cancer Therapeutics [J].

Amouzegar, Afsaneh ;

Chelvanambi, Manoj ;

Filderman, Jessica N. ;

Storkus, Walter J. ;

Luke, Jason J. .

CANCERS, 2021, 13 (11)

[2] Inducible Tertiary Lymphoid Structures: Promise and Challenges for Translating a New Class of Immunotherapy [J].

Aoyama, Shota ;

Nakagawa, Ryosuke ;

Mule, James J. ;

Mailloux, Adam W. .

FRONTIERS IN IMMUNOLOGY, 2021, 12

[3] Fundamental Concepts of Hydrogels: Synthesis, Properties, and Their Applications [J].

Bashir, Shahid ;

Hina, Maryam ;

Iqbal, Javed ;

Rajpar, A. H. ;

Mujtaba, M. A. ;

Alghamdi, N. A. ;

Wageh, S. ;

Ramesh, K. ;

Ramesh, S. .

POLYMERS, 2020, 12 (11) :1-60

[4] Mature tertiary lymphoid structure is a specific biomarker of cancer immunotherapy and does not predict outcome to chemotherapy in non-small-cell lung cancer [J].

Brunet, M. ;

Crombe, A. ;

Cousin, S. ;

Vanhersecke, L. ;

Le Loarer, F. ;

Bessede, A. ;

Italiano, A. .

ANNALS OF ONCOLOGY, 2022, 33 (10) :1084-1085

[5] Stromal Cells in Chronic Inflammation and Tertiary Lymphoid Organ Formation [J].

Buckley, Christopher D. ;

Barone, Francesca ;

Nayar, Saba ;

Benezech, Cecile ;

Caamano, Jorge .

ANNUAL REVIEW OF IMMUNOLOGY VOL 33, 2015, 33 :715-745

[6] Tertiary lymphoid structures improve immunotherapy and survival in melanoma [J].

Cabrita, Rita ;

Lauss, Martin ;

Sanna, Adriana ;

Donia, Marco ;

Larsen, Mathilde Skaarup ;

Mitra, Shamik ;

Johansson, Iva ;

Phung, Bengt ;

Harbst, Katja ;

Vallon-Christersson, Johan ;

van Schoiack, Alison ;

Loevgren, Kristina ;

Warren, Sarah ;

Jirstroem, Karin ;

Olsson, Hakan ;

Pietras, Kristian ;

Ingvar, Christian ;

Isaksson, Karolin ;

Schadendorf, Dirk ;

Schmidt, Henrik ;

Bastholt, Lars ;

Carneiro, Ana ;

Wargo, Jennifer A. ;

Svane, Inge Marie ;

Jonsson, Goran .

NATURE, 2020, 577 (7791) :561-+

[7] Intra-tumoral tertiary lymphoid structures are associated with a low risk of early recurrence of hepatocellular carcinoma [J].

Calderaro, Julien ;

Petitprez, Florent ;

Becht, Etienne ;

Laurent, Alexis ;

Hirsch, Theo Z. ;

Rousseau, Benoit ;

Luciani, Alain ;

Amaddeo, Giuliana ;

Derman, Jonathan ;

Charpy, Cecile ;

Zucman-Rossi, Jessica ;

Fridman, Wolf Herman ;

Sautes-Fridman, Catherine .

JOURNAL OF HEPATOLOGY, 2019, 70 (01) :58-65

[8] Comparing and contrasting predictive biomarkers for immunotherapy and targeted therapy of NSCLC [J].

Camidge, D. Ross ;

Doebele, Robert C. ;

Kerr, Keith M. .

NATURE REVIEWS CLINICAL ONCOLOGY, 2019, 16 (06) :341-355

[9]

Castellanos EH, 2016, CANCER TREAT RES, V170, P203, DOI 10.1007/978-3-319-40389-2_10

[10] TGF-β-mediated silencing of genomic organizer SATB1 promotes Tfh cell differentiation and formation of intra-tumoral tertiary lymphoid structures [J].

Chaurio, Ricardo A. ;

Anadon, Carmen M. ;

Costich, Tara Lee ;

Payne, Kyle K. ;

Biswas, Subir ;

Harro, Carly M. ;

Moran, Carlos ;

Ortiz, Antonio C. ;

Cortina, Carla ;

Rigolizzo, Kristen E. ;

Sprenger, Kimberly B. ;

Mine, Jessica A. ;

Innamarato, Patrick ;

Mandal, Gunjan ;

Powers, John J. ;

Martin, Alexandra ;

Wang, Zhitao ;

Mehta, Sumit ;

Perez, Bradford A. ;

Li, Roger ;

Robinson, John ;

Kroeger, Jodi L. ;

Curiel, Tyler J. ;

Yu, Xiaoqing ;

Rodriguez, Paulo C. ;

Conejo-Garcia, Jose R. .

IMMUNITY, 2022, 55 (01) :115-+

← 1 2 3 4 5 6 7 8 9 10 →